Related Experiment Video
Updated: Aug 14, 2025
10:30
Visualization of IL-22-expressing Lymphocytes Using Reporter Mice
Published on: January 25, 2017
8.9K
Two faces: IL-22 effects prevail over defense against metastasis
1Cancer Immunology Unit, University College London (UCL), Cancer Institute, London WC1E 6DD, UK.
Immunity
|January 11, 2023
Summary
Interleukin-22 (IL-22) is a cytokine that can promote cancer metastasis. New research shows IL-22
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Interleukin-22 (IL-22) is a pleiotropic cytokine with diverse roles in homeostasis and disease.
- The specific contribution of IL-22 to cancer progression, particularly metastasis, remains incompletely understood.
Purpose of the Study:
- To elucidate the role of IL-22 in promoting cancer metastasis.
- To identify the mechanisms by which IL-22 influences the metastatic cascade.
Main Methods:
- Utilized genetically engineered mouse models.
- Performed in vivo and in vitro assays to assess tumor growth and metastasis.
- Analyzed cytokine expression and signaling pathways.
Main Results:
- Demonstrated that IL-22 actively promotes the formation of cancer metastasis.
- Identified specific pathways through which IL-22 enhances tumor cell dissemination and survival at secondary sites.
Conclusions:
- IL-22 plays a significant role in advancing cancer metastasis.
- Targeting IL-22 may represent a novel therapeutic strategy to inhibit cancer spread.
Related Concept Videos
02:17The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
02:30Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
01:24T Cell Types and Functions
1.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.2K
01:27Tumor Immunotherapy
621
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
621